Key points of American guidelines for the diagnosis and treatment of Clostridium difficile infectionJIA Tian-ye, TANG Yi-wei, QU Fen193-196
Updated treatment protocol for direct-acting antiviral agents for hepatitis CZHANG Xia-xia, XU Xiao-yuan197-199
Research progress of the correlation between intestinal microbiota and nonalcoholic fatty liver diseaseZHOU Da, FAN Jian-gao200-202,206
Recent advances in association between vaginal flora and bacterial vaginosisZHANG Rui-fen, ZHU Bao-li203-206
Serological survey of past infection with a novel reovirus in different populationsHU Yan, MAO Da, LIU Ze, JIANG Qi-yu, XIE Guo-ming, BAI Bing-ke207-209
Application and evaluation of mass spectrometry in identification of fungal infectionWANG Huan, JIA Tian-ye, BAO Chun-mei, ZHANG Cheng-long, ZHANG Ju-Ling, CUI En-bo, CHEN Su-ming, XU dong-ping, QU Fen210-214
Characteristics of resistance of Mycobacterium tuberculosis to rifamycins in clinical isolatesYANG Li-kun, SUN Wen-na, WANG Xin-jing, WANG Zhong-yuan, CHENG Xiao-xing215-216,222
Efficacy and safety of telbivudine versus lamivudine in interrupting mother-to-child transmission of HBV:a meta-analysisWANG Li, ZHANG Yan-qiong, WANG Yu-ming, HE Yun217-222
Value of transient elastography and serologic markers of liver fibrosis in diagnosing liver fibrosis in liver transplant patientsHE Xi, YANG Shuo, NIU Zi-chang, TANG Ru-jia, ZHANG Da-li, ZHOU Xia, ZHOU Shuang-nan, SU Hai-bin, LIU Zhen-wen, ZHANG Min223-226
Predictive value of interleukin-32 and matrix metalloproteinases-2 in peripheral blood for the prognosis of HBV-related acute-on-chronic liver failureCAO Li, WANG Mei-hua, ZOU Mei-yin, ZHU Yong-gen227-230